Analysis of Cytokine Levels Based on Optical Coherence Tomography Findings in Acute and Chronic Central Serous Chorioretinopathy

References

• Kaye R, Chandra S, Sheth J, Boon CJF, Sivaprasad S, Lotery A. Central serous chorioretinopathy: an update on risk factors, pathophysiology and imaging modalities. Prog Retin Eye Res. 2020; 79:100865. doi: 10.1016/j.preteyeres.2020.100865.
   PubMed Web of Science ®Google Scholar
• van Rijssen TJ, van Dijk EHC, Yzer S, Ohno-Matsui K, Keunen JEE, Schlingemann RO, Sivaprasad S, Querques G, Downes SM, Fauser S, et al. Central serous chorioretinopathy: towards an evidence-based treatment guideline. Prog Retin Eye Res. 2019; 73:100770. doi: 10.1016/j.preteyeres.2019.07.003.
   PubMed Web of Science ®Google Scholar
• Daruich A, Matet A, Dirani A, Bousquet E, Zhao M, Farman N, Jaisser F, Behar-Cohen F. Central serous chorioretinopathy: recent findings and new physiopathology hypothesis. Prog Retin Eye Res. 2015; 48:82–118. doi: 10.1016/j.preteyeres.2015.05.003.
   PubMed Web of Science ®Google Scholar
• Iglicki M, Busch C, Loewenstein A, Fung AT, Invernizzi A, Mariussi M, Arias R, Gabrielle PH, Cebeci Z, Okada M, et al. Underdiagnosed optic disk pit maculopathy: spectral domain optical coherence tomography features for accurate diagnosis. Retina. 2019;39(11):2161–2166. doi: 10.1097/IAE.0000000000002270.
   PubMed Web of Science ®Google Scholar
• Nkrumah G N, Paez-Escamilla M, Singh SR, Rasheed MA, Maltsev D, Guduru A, Chhablani J. Biomarkers for central serous chorioretinopathy. Ther Adv Ophthalmol. 2020; 12:2515841420950846. doi: 10.1177/2515841420950846.
   Web of Science ®Google Scholar
• Yalcinbayir O, Gelisken O, Akova-Budak B, Ozkaya G, Gorkem Cevik S, Yucel AA. Correlation of spectral domain optical coherence tomography findings and visual acuity in central serous chorioretinopathy. Retina. 2014;34(4):705–712. doi: 10.1097/IAE.0000000000000001.
   PubMed Web of Science ®Google Scholar
• Lee H, Lee J, Chung H, Kim HC. Baseline spectral domain optical coherence tomographic hyperreflective foci as a predictor of visual outcome and recurrence for central serous chorioretinopathy. Retina. 2016;36(7):1372–1380. doi: 10.1097/IAE.0000000000000929.
   PubMed Web of Science ®Google Scholar
• Terao N, Koizumi H, Kojima K, Yamagishi T, Nagata K, Kitazawa K, Yamamoto Y, Yoshii K, Hiraga A, Toda M, et al. Association of upregulated angiogenic cytokines with choroidal abnormalities in chronic central serous chorioretinopathy. Invest Ophthalmol Vis Sci. 2018;59(15):5924–5931. doi: 10.1167/iovs.18-25517.
   PubMed Web of Science ®Google Scholar
• Jung SH, Kim KA, Sohn SW, Yang SJ. Cytokine levels of the aqueous humour in central serous chorioretinopathy. Clin Exp Optom. 2014;97(3):264–269. doi: 10.1111/cxo.12125.
   PubMed Web of Science ®Google Scholar
• Lim JW, Kim MU, Shin MC. Aqueous humor and plasma levels of vascular endothelial growth factor and interleukin-8 in patients with central serous chorioretinopathy. Retina. 2010;30(9):1465–1471. doi: 10.1097/IAE.0b013e3181d8e7fe.
   PubMed Web of Science ®Google Scholar
• Shin MC, Lim JW. Concentration of cytokines in the aqueous humor of patients with central serous chorioretinopathy. Retina. 2011;31(9):1937–1943. doi: 10.1097/IAE.0b013e31820a6a17.
   PubMed Web of Science ®Google Scholar
• Lee H, Jang H, Choi YA, Kim HC, Chung H. Association between soluble CD14 in the aqueous humor and hyperreflective foci on optical coherence tomography in patients with diabetic macular edema. Invest Ophthalmol Vis Sci. 2018;59(2):715–721. doi: 10.1167/iovs.17-23042.
   PubMed Web of Science ®Google Scholar
• Li M, Li J, Chen K, Wang J, Sheng M, Li B. Association between inflammatory factors in the aqueous humor and hyperreflective foci in patients with intractable macular edema treated with antivascular endothelial growth factor. Dis Markers. 2021; 2021:5552824. doi: 10.1155/2021/5552824.
   PubMed Web of Science ®Google Scholar
• Fragiotta S, Abdolrahimzadeh S, Dolz-Marco R, Sakurada Y, Gal-Or O, Scuderi G. Significance of hyperreflective foci as an optical coherence tomography biomarker in retinal diseases: characterization and clinical implications. J Ophthalmol. 2021; 2021:6096017. doi: 10.1155/2021/6096017.
   PubMed Web of Science ®Google Scholar
• Kitazawa K, Sotozono C, Koizumi N, Nagata K, Inatomi T, Sasaki H, Kinoshita S. Safety of anterior chamber paracentesis using a 30-gauge needle integrated with a specially designed disposable pipette. Br J Ophthalmol. 2017;101(5):548–550. doi: 10.1136/bjophthalmol-2016-309650.
   PubMed Web of Science ®Google Scholar
• Shinojima A, Kawamura A, Mori R, Fujita K, Yuzawa M. Findings of optical coherence tomographic angiography at the choriocapillaris level in central serous chorioretinopathy. Ophthalmologica. 2016;236(2):108–113. doi: 10.1159/000448436.
   PubMed Web of Science ®Google Scholar
• Jeong S, Kang W, Noh D, van Hemert J, Sagong M. Choroidal vascular alterations evaluated by ultra-widefield indocyanine green angiography in central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol. 2022;260(6):1887–1898. doi: 10.1007/s00417-021-05461-0.
   PubMed Web of Science ®Google Scholar
• Schellevis RL, van Dijk EHC, Breukink MB, Altay L, Bakker B, Koeleman BPC, Kiemeney LA, Swinkels DW, Keunen JEE, Fauser S, et al. Role of the complement system in chronic central serous chorioretinopathy: a genome-wide association study. JAMA Ophthalmol. 2018;136(10):1128–1136. doi: 10.1001/jamaophthalmol.2018.3190.
   PubMed Web of Science ®Google Scholar
• Nourinia R, Ahmadieh H, Nekoei E, Malekifar P, Tofighi Z. Changes in central choroidal thickness after treatment of diabetic macular edema with intravitreal bevacizumab correlation with central macular thickness and best-corrected visual acuity. Retina. 2018;38(5):970–975. doi: 10.1097/IAE.0000000000001645.
   PubMed Web of Science ®Google Scholar
• Mao J, Zhang C, Zhang S, Liu C, Chen N, Tao J, She X, Zheng Z, Lv Z, Shen L. Predictors of anti-VEGF efficacy in chronic central serous chorioretinopathy based on intraocular cytokine levels and pigment epithelium detachment subtypes. Acta Ophthalmol. 2022;100(7):e1385–e1394.
   PubMed Web of Science ®Google Scholar
• Song IS, Shin YU, Lee BR. Time-periodic characteristics in the morphology of idiopathic central serous chorioretinopathy evaluated by volume scan using spectral-domain optical coherence tomography. Am J Ophthalmol. 2012;154(2):366–375.e4. doi: 10.1016/j.ajo.2012.02.031.
   PubMed Web of Science ®Google Scholar
• Iglicki M, Busch C, Zur D, Okada M, Mariussi M, Chhablani JK, Cebeci Z, Fraser-Bell S, Chaikitmongkol V, Couturier A, et al. Dexamethasone implant for diabetic macular edema in naive compared with refractory eyes: the international retina group real-life 24-month multicenter study. The IRGREL-DEX study. Retina. 2019;39(1):44–51. doi: 10.1097/IAE.0000000000002196.
   PubMed Web of Science ®Google Scholar
• Ding X, Hu Y, Yu H, Li Q. Changes of optical coherence tomography biomarkers in macular edema secondary to retinal vein occlusion after anti-VEGF and anti-inflammatory therapies. Drug Des Devel Ther. 2022; 16:717–725. doi: 10.2147/DDDT.S351683.
   PubMed Web of Science ®Google Scholar
• Iglicki M, González DP, Loewenstein A, Zur D. Next-generation anti-VEGF agents for diabetic macular oedema. Eye. 2022;36(2):273–277. doi: 10.1038/s41433-021-01722-8.
   PubMed Web of Science ®Google Scholar
• Joo JH, Kim H, Shin JH, Moon SW. Aqueous humor cytokine levels through microarray analysis and a sub-analysis based on optical coherence tomography in wet age-related macular degeneration patients. BMC Ophthalmol. 2021;21(1):399. doi: 10.1186/s12886-021-02152-6.
   PubMed Web of Science ®Google Scholar
• Hodge DL, Reynolds D, Cerbán FM, Correa SG, Baez NS, Young HA, Rodriguez-Galan MC. MCP-1/CCR2 interactions direct migration of peripheral B and T lymphocytes to the thymus during acute infectious/inflammatory processes. Eur J Immunol. 2012;42(10):2644–2654. doi: 10.1002/eji.201242408.
   PubMed Web of Science ®Google Scholar